Is there a connection between estrogen and Parkinson’s disease?

Anesthesiology

Wiklund, R. A., & Rosenbaum, S. H. (1997) · New England Journal of Medicine · doi:10.1056/nejm199710163371606 · Cited by 2,159 · see citing works

Parkinson's Disease

Lang, A. E., & Lozano, A. M. (1998) · New England Journal of Medicine · doi:10.1056/nejm199810083391506 · Cited by 2,041 · see citing works

Differential Ligand Activation of Estrogen Receptors ERα and ERβ at AP1 Sites

Paech, K., Webb, P., Kuiper, G. G. J. M., Nilsson, S., Gustafsson, J.-Å., Kushner, P. J., & Scanlan, T. S. (1997) · Science · doi:10.1126/science.277.5331.1508 · Cited by 1,861 · see citing works

Cell Membrane and Nuclear Estrogen Receptors (ERs) Originate from a Single Transcript: Studies of ERα and ERβ Expressed in Chinese Hamster Ovary Cells

Razandi, M., Pedram, A., Greene, G. L., & Levin, E. R. (1999) · Molecular Endocrinology · doi:10.1210/mend.13.2.0239 · Cited by 1,046 · see citing works

Estrogen Stimulates a Transient Increase in the Number of New Neurons in the Dentate Gyrus of the Adult Female Rat

Tanapat, P., Hastings, N. B., Reeves, A. J., & Gould, E. (1999) · Journal of Neuroscience · doi:10.1523/jneurosci.19-14-05792.1999 · Cited by 978 · see citing works

Estrogens Attenuate and Corticosterone Exacerbates Excitotoxicity, Oxidative Injury, and Amyloid β‐Peptide Toxicity in Hippocampal Neurons

Goodman, Y., Bruce‐Keller, A. J., Cheng, B., & Mattson, M. P. (1996) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1996.66051836.x · Cited by 830 · see citing works

Steroid Receptor Family: Structure and Functions

Carson, M. A., Schrader, W. T., & O’Malley, B. W. (1990) · Endocrine Reviews · doi:10.1210/edrv-11-2-201 · Cited by 811 · see citing works

Neuroprotection against Oxidative Stress by Estrogens: Structure-Activity Relationship

Behl, C., Skutella, T., Lezoualc’h, F., Post, A., Widmann, M., Newton, C. J., & Holsboer, F. (1997) · Molecular Pharmacology · doi:10.1124/mol.51.4.535 · Cited by 762 · see citing works

Estradiol reduces calcium currents in rat neostriatal neurons via a membrane receptor

Mermelstein, P. G., Becker, J., & Surmeier, D. J. (1996) · Journal of Neuroscience · doi:10.1523/jneurosci.16-02-00595.1996 · Cited by 633 · see citing works

Membrane estrogen receptors identified by multiple antibody labeling and impeded‐ligand binding

Pappas, T. C., Gametchu, B., & Watson, C. S. (1995) · The FASEB Journal · doi:10.1096/fasebj.9.5.7896011 · Cited by 533 · see citing works

Animal models of Parkinson's disease: An empirical comparison with the phenomenology of the disease in man

Gerlach, M., & Riederer, P. F. (1996) · Journal of Neural Transmission · doi:10.1007/bf01291788 · Cited by 496 · see citing works

Estrogen-Mediated Structural and Functional Synaptic Plasticity in the Female Rat Hippocampus

Woolley, C. S. (1998) · Hormones and Behavior · doi:10.1006/hbeh.1998.1466 · Cited by 387 · see citing works

Cell Membrane and Nuclear Estrogen Receptors (ERs) Originate from a Single Transcript: Studies of ER and ER Expressed in Chinese Hamster Ovary Cells

Razandi, M. (1999) · Molecular Endocrinology · doi:10.1210/me.13.2.307 · Cited by 385 · see citing works

A Population-Based Investigation of Parkinson's Disease With and Without Dementia

Mayeux, R. P. (1992) · Archives of Neurology · doi:10.1001/archneur.1992.00530290076015 · Cited by 383 · see citing works

Direct effect of 17β‐estradiol on striatum: Sex differences in dopamine release

Becker, J. B. (1990) · Synapse · doi:10.1002/syn.890050211 · Cited by 360 · see citing works

Neuroprotection through Delivery of Glial Cell Line-Derived Neurotrophic Factor by Neural Stem Cells in a Mouse Model of Parkinson's Disease

Åkerud, P., Canals, J. M., Snyder, E. Y., & Arenas, E. (2001) · Journal of Neuroscience · doi:10.1523/jneurosci.21-20-08108.2001 · Cited by 303 · see citing works

Estrogen rapidly potentiates amphetamine-induced striatal dopamine release and rotational behavior during microdialysis

Becker, J. B. (1990) · Neuroscience Letters · doi:10.1016/0304-3940(90)90618-j · Cited by 287 · see citing works

Sex steroids and affect in the surgical menopause: a double-blind, cross-over study

Sherwin, B. B. (1985) · Psychoneuroendocrinology · doi:10.1016/0306-4530(85)90009-5 · Cited by 285 · see citing works

The effect of estrogen replacement on early Parkinson’s disease

Saunders-Pullman, R. J., Gordon-Elliott, J. S., Parides, M. K., Fahn, S., Saunders, H. R., & Bressman, S. (1999) · Neurology · doi:10.1212/wnl.52.7.1417 · Cited by 270 · see citing works

Sex difference and estrous cycle variations in amphetamine-elicited rotational behavior

Becker, J. B., Robinson, T. E., & Lorenz, K. A. (1982) · European Journal of Pharmacology · doi:10.1016/0014-2999(82)90178-9 · Cited by 268 · see citing works

Estrogen Is Essential for Maintaining Nigrostriatal Dopamine Neurons in Primates: Implications for Parkinson's Disease and Memory

Léránth, C., Roth, R. H., Elsworth, J. D., Naftolin, F. N., Horváth, T. L., & Redmond, D. E. (2000) · Journal of Neuroscience · doi:10.1523/jneurosci.20-23-08604.2000 · Cited by 267 · see citing works

Affective changes with estrogen and androgen replacement theraphy in surgically menopausal women

Sherwin, B. B. (1988) · Journal of Affective Disorders · doi:10.1016/0165-0327(88)90061-4 · Cited by 258 · see citing works

Sex differences in striatal dopamine: in vivo microdialysis and behavioral studies

Castner, S. A., Li, X., & Becker, J. B. (1993) · Brain Research · doi:10.1016/0006-8993(93)91225-h · Cited by 253 · see citing works

Estradiol protects mesencephalic dopaminergic neurons from oxidative stress-induced neuronal death

Sawada, H., Ibi, M., Kihara, T., Urushitani, M., Akaike, A., & Shimohama, S. (1998) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19981201)54:5 · Cited by 246 · see citing works

When does estrogen replacement therapy improve sleep quality?

Polo-Kantola, P., Erkkola, R., Helenius, H., Irjala, K., & Polo, O. (1998) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(98)70539-3 · Cited by 242 · see citing works

Effects of Estrogen Replacement on the Relative Levels of Choline Acetyltransferase, trkA, and Nerve Growth Factor Messenger RNAs in the Basal Forebrain and Hippocampal Formation of Adult Rats

Gibbs, R. B., Wu, D., Hersh, L. B., & Pfaff, D. W. (1994) · Experimental Neurology · doi:10.1006/exnr.1994.1148 · Cited by 233 · see citing works

The Molecular and Neuroanatomical Basis for Estrogen Effects in the Central Nervous System

McEwen, B. S. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.6.5761 · Cited by 227 · see citing works

Sex differences in the rapid and acute effects of estrogen on striatal D2 dopamine receptor binding

Bazzett, T. J., & Becker, J. B. (1994) · Brain Research · doi:10.1016/0006-8993(94)91229-7 · Cited by 222 · see citing works

Sex differences in the amphetamine stimulated release of catecholamines from rat striatal tissue in vitro

Becker, J. B., & RAMIREZ, V. D. (1981) · Brain Research · doi:10.1016/0006-8993(81)90595-3 · Cited by 211 · see citing works

Estrogen improves motor disability in parkinsonian postmenopausal women with motor fluctuations

Tsang, K., Ho, S.-L., & Lo, S. K. (2000) · Neurology · doi:10.1212/wnl.54.12.2292 · Cited by 204 · see citing works

Acute Stimulatory Effect of Estradiol on Striatal Dopamine Synthesis

Pasqualini, C., Olivier, V., Guibert, B., Frain, O., & Leviel, V. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.65041651.x · Cited by 201 · see citing works

Distribution of estrogen receptor beta (ERβ) mRNA in hypothalamus, midbrain and temporal lobe of spayed macaque: continued expression with hormone replacement

Gundlah, C., Kohama, S. G., Mirkes, S. J., Garyfallou, V. T., Urbanski, H. F., & Bethea, C. L. (2000) · Molecular Brain Research · doi:10.1016/s0006-8993(99)02475-0 · Cited by 199 · see citing works

ŒSTROGENS AND EXTRAPYRAMIDAL SYSTEM

Bédard, P. J., Langelier, P., & Villeneuve, A. (1977) · The Lancet · doi:10.1016/s0140-6736(77)90429-9 · Cited by 179 · see citing works

The influence of estrogen on nigrostriatal dopamine activity

Becker, J. B., & Beer, M. E. (1986) · Behavioural Brain Research · doi:10.1016/0166-4328(86)90044-6 · Cited by 177 · see citing works

The influence of estrous cycle and intrastriatal estradiol on sensorimotor performance in the female rat

Becker, J. B., Snyder, P. J., Miller, M. M., Westgate, S. A., & Jenuwine, M. J. (1987) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(87)90476-x · Cited by 164 · see citing works

Estrogen as a neuroprotectant against MPTP-Induced neurotoxicity in C57/B1 mice

Dluzen, D. E., McDermott, J. L., & Liu, B. (1996) · Neurotoxicology and Teratology · doi:10.1016/0892-0362(96)00086-4 · Cited by 163 · see citing works

Mechanisms of antiapoptotic effects of estrogens in nigral dopaminergic neurons

Sawada, H., Ibi, M., Kihara, T., Urushitani, M., Honda, K., Nakanishi, M., Akaike, A., & Shimohama, S. (2000) · The FASEB Journal · doi:10.1096/fasebj.14.9.1202 · Cited by 154 · see citing works

Postmenopausal estrogen use and Parkinson's disease with and without dementia

Marder, K. S., Tang, M. X., Alfaro, B., Mejía, H., Cote, L. J., Jacobs, D. M., Stern, Y., Sano, M. C., & Mayeux, R. P. (1998) · Neurology · doi:10.1212/wnl.50.4.1141 · Cited by 153 · see citing works

Effect of short-term transdermal estrogen replacement therapy on sleep: a randomized, double-blind crossover trial in postmenopausal women

Polo‐Kantola, P., Erkkola, R., Irjala, K. M. A., Pullinen, S., Virtanen, I., & Polo, O. J. (1999) · Fertility and Sterility · doi:10.1016/s0015-0282(99)00062-x · Cited by 143 · see citing works

Estrogen decreases corpus striatal neurotoxicity in response to 6-hydroxydopamine

Dluzen, D. E. (1997) · Brain Research · doi:10.1016/s0006-8993(97)00630-6 · Cited by 143 · see citing works

Role of High‐Affinity Dopamine Uptake and Impulse Activity in the Appearance of Extracellular Dopamine in Striatum After Administration of Exogenous L‐DOPA

Miller, D. W., & Abercrombie, E. D. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.721516.x · Cited by 138 · see citing works

Nongenomic effects of oestrogen: embryonic mouse midbrain neurones respond with a rapid release of calcium from intracellular stores

Beyer, C., & Raab, H. (1998) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.1998.00045.x · Cited by 138 · see citing works

Effect of Chronic Estradiol and Progesterone Treatments of Ovariectomized Rats on Brain Dopamine Uptake Sites

Morissette, M., & Paolo, T. D. (1993) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1993.tb13415.x · Cited by 135 · see citing works

The role of transition metals in the pathogenesis of Parkinson's disease.

Kienzl, E., Puchinger, L., Jellinger, K., Linert, W., Stachelberger, H., & Jameson, R. (1995) · Journal of Neurological Sciences · doi:10.1016/0022-510x(95)00210-s · Cited by 129 · see citing works

Short-term effects of high-dose 17β-estradiol in postmenopausal PD patients

Blanchet, P. J., Fang, J. Y., Hyland, Κ., Arnold, L. A., Mouradian, M. M., & Chase, T. N. (1999) · Neurology · doi:10.1212/wnl.53.1.91 · Cited by 129 · see citing works

Rapid conversion of high into low striatal D2-dopamine receptor agonist binding states after an acute physiological dose of 17β-estradiol

Lévesque, D., & Paolo, T. D. (1988) · Neuroscience Letters · doi:10.1016/0304-3940(88)90324-2 · Cited by 129 · see citing works

Estrogen Alters MPTP‐Induced Neurotoxicity in Female Mice: Effects on Striatal Dopamine Concentrations and Release

Dluzen, D. E., McDermott, J. L., & Liu, B. (1996) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1996.66020658.x · Cited by 126 · see citing works

Sex Differences and Effects of Estrogen on Dopamine and DOPAC Release from the Striatum of Male and Female CD-1 Mice

McDermott, J. L., Liu, B., & Dluzent, D. E. (1994) · Experimental Neurology · doi:10.1006/exnr.1994.1034 · Cited by 123 · see citing works

Interactions of Estrogen with the Neurotrophins and Their Receptors during Neural Development

Miranda, R. C., Sohrabji, F., & Toran‐Allerand, D. (1994) · Hormones and Behavior · doi:10.1006/hbeh.1994.1033 · Cited by 122 · see citing works

Gender differences in neurotoxicity of the nigrostriatal dopaminergic system: implications for Parkinson's disease.

De, D., & McDermott, J. L. (2001) · PubMed · Cited by 118 · see citing works

Steady‐State Pharmacokinetic Properties of Pramipexole in Healthy Volunteers

Wright, C. E., Sisson, T. L., Ichhpurani, A. K., & Peters, G. R. (1997) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1997.tb04330.x · Cited by 117 · see citing works

Parkinson disease: etiology, pathogenesis and future of gene therapy

Shastry, B. S. (2001) · Neuroscience Research · doi:10.1016/s0168-0102(01)00254-1 · Cited by 115 · see citing works

Striatal D-2 dopamine agonist binding sites fluctuate during the rat estrous cycle

Paolo, T. D., Falardeau, P., & Morissette, M. (1988) · Life Sciences · doi:10.1016/0024-3205(88)90137-3 · Cited by 109 · see citing works

Pathology of Symptomatic Tremors

Vidailhet, M., Jedynak, C.-P., Pollak, P., & Agid, Y. (2008) · Movement Disorders · doi:10.1002/mds.870131309 · Cited by 108 · see citing works

Better postural balance in elderly women receiving estrogens

Naessén, T., Lindmark, B., & Larsen, H.-C. (1997) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(97)70207-2 · Cited by 99 · see citing works

Estrogen treatment of dyskinetic disorders

Koller, W. C., Barr, A., & Biary, N. M. (1982) · Neurology · doi:10.1212/wnl.32.5.547 · Cited by 97 · see citing works

Presumptive Estrogen Target Neurons Express mRNAs for both the Neurotrophins and Neurotrophin Receptors: A Basis for Potential Developmental Interactions of Estrogen with the Neurotrophins

Miranda, R. C., Sohrabji, F., & Toran‐Allerand, C. D. (1993) · Molecular and Cellular Neuroscience · doi:10.1006/mcne.1993.1063 · Cited by 93 · see citing works

Effect of estradiol and progesterone on rat striatal dopamine uptake sites

Morissette, M., Biron, D., & Paolo, T. D. (1990) · Brain Research Bulletin · doi:10.1016/0361-9230(90)90231-n · Cited by 84 · see citing works

Up-regulatory effect of estrogen on platelet 3H-imipramine binding sites in surgically menopausal women

Sherwin, B. B., & Suranyi-Cadotte, B. E. (1990) · Biological Psychiatry · doi:10.1016/0006-3223(90)90661-k · Cited by 83 · see citing works

Cortical inputs to m2-immunoreactive striatal interneurons in rat and monkey

Thomas, T. M., Smith, Y., Levey, A. I., & Hersch, S. M. (2000) · Synapse · doi:10.1002/1098-2396(20000915)37:4 · Cited by 81 · see citing works

On the function of neuromelanin

Smythies, J. (1996) · Proceedings of the Royal Society B Biological Sciences · doi:10.1098/rspb.1996.0073 · Cited by 76 · see citing works

Estrogen as a neuromodulator of MPTP-induced neurotoxicity: effects upon striatal dopamine release

Disshon, K. A., & Dluzen, D. E. (1997) · Brain Research · doi:10.1016/s0006-8993(97)00418-6 · Cited by 73 · see citing works

Estrogen stimulates brain‐derived neurotrophic factor expression in embryonic mouse midbrain neurons through a membrane‐mediated and calcium‐dependent mechanism

Ivanova, T., Küppers, E., Engele, J., & Beyer, C. (2001) · Journal of Neuroscience Research · doi:10.1002/jnr.1214 · Cited by 72 · see citing works

Sex differences and estrous cycle dependent variation in rotational behavior elicited by electrical stimulation of the mesostriatal dopamine system

Robinson, T. E., Camp, D. M., Jacknow, D. S., & Becker, J. B. (1982) · Behavioural Brain Research · doi:10.1016/0166-4328(82)90028-6 · Cited by 68 · see citing works

Lesion-Induced Increase of BDNF Is Greater in the Striatum of Young versus Old Rat Brain

Yurek, D. M., & Fletcher‐Turner, A. (2000) · Experimental Neurology · doi:10.1006/exnr.1999.7274 · Cited by 64 · see citing works

The BDNF content of postnatal and adult rat brain: the effects of 6-hydroxydopamine lesions in adult brain

Zhou, J., Pliego‐Rivero, B., Bradford, H. F., & Stern, G. M. (1996) · Developmental Brain Research · doi:10.1016/s0165-3806(96)00159-9 · Cited by 62 · see citing works

Chronic estrogen treatment replaces striatal dopaminergic function in ovariectomized rats

Ohtani, H., Nomoto, M., & Douchi, T. (2001) · Brain Research · doi:10.1016/s0006-8993(01)02276-4 · Cited by 61 · see citing works

Effect of estrogen and progesterone on l-DOPA induced dyskinesia in MPTP-treated monkeys

Gomez‐Mancilla, B., & Bédard, P. J. (1992) · Neuroscience Letters · doi:10.1016/0304-3940(92)90152-w · Cited by 60 · see citing works

Estrogen therapy for depression in postmenopausal women

Carranza‐Lira, S., & Valentino‐Figueroa, M. L. (1999) · International Journal of Gynecology & Obstetrics · doi:10.1016/s0020-7292(99)00017-x · Cited by 59 · see citing works

Glial Cell Line-Derived Neurotrophic Factor: A Novel Therapeutic Approach to Treat Motor Dysfunction in Parkinson's Disease

Lapchak, P. A., Gash, D. M., Jiao, S., Miller, P. J., & Hilt, D. C. (1997) · Experimental Neurology · doi:10.1006/exnr.1996.6384 · Cited by 51 · see citing works

Genetic Epidemiology of Parkinson's Disease

Payami, H., & Zareparsi, S. (1998) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/089198879801100207 · Cited by 49 · see citing works

Estrogen modulates responses of striatal dopamine neurons to MPP+: evaluations using in vitro and in vivo techniques

Arvin, M., Fedorková, L., Disshon, K. A., Dluzen, D. E., & Leipheimer, R. E. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02511-7 · Cited by 43 · see citing works

In vitro Dopamine Release from the Rat Striatum: Diurnal Rhythm and Its Modification by the Estrous Cycle

Dluzen, D. E., & Ramirez, V. D. (2008) · Neuroendocrinology · doi:10.1159/000124160 · Cited by 39 · see citing works

Nigrostriatal and mesolimbic dopaminergic activities were modified throughout the ovarian cycle of female rats

Fern�ndez-Ruiz, J. J., Hern�ndez, M. L., Miguel, R., & Ramos, J. A. (1991) · Journal of Neural Transmission · doi:10.1007/bf01244947 · Cited by 36 · see citing works

Modifications of the Striatal Dopamine Metabolism during the Estrus Cycle in Mice

Jori, A., Colturani, F., Dolfini, E., & Rutczyński, M. (2008) · Neuroendocrinology · doi:10.1159/000122531 · Cited by 36 · see citing works

Rapid stimulation of striatal dopamine synthesis by estradiol

Pasqualini, C., Olivier, V., Guibert, B., Frain, O., & Leviel, V. (1996) · Cellular and Molecular Neurobiology · doi:10.1007/bf02088105 · Cited by 29 · see citing works

Parkinson's disease. Update in diagnosis and symptom management.

Marjama-Lyons, J., & Koller, W. C. (2001) · PubMed · Cited by 28 · see citing works

Potential of gene therapy for Parkinson's disease: neurobiologic issues and new developments in gene transfer methodologies.

Kang, U. J. (1998) · PubMed · Cited by 20 · see citing works

In vivo changes in responsiveness of the caudate nucleus tol-DOPA infusion as a function of the estrous cycle

Dluzen, D. E., & Ramirez, V. D. (1990) · Brain Research · doi:10.1016/0006-8993(90)90021-3 · Cited by 16 · see citing works

Novel Mechanisms of Estrogen Action in the Developing Brain

Toran‐Allerand, C. D. (1999) · Humana Press eBooks · doi:10.1007/978-1-59259-693-5_17 · Cited by 9 · see citing works

Untitled work

(2000) · doi:10.1002/1531-8257(200011)15:6

Estrogen receptors and human disease

Deroo, B. J. (2006) · Journal of Clinical Investigation · doi:10.1172/jci27987 · Cited by 1,322 · see citing works

Epidemiology and etiology of Parkinson's disease: a review of the evidence

Wirdefeldt, K., Adami, H.-O., Cole, P., Trichopoulos, D., & Mandel, J. (2011) · European Journal of Epidemiology · doi:10.1007/s10654-011-9581-6 · Cited by 1,199 · see citing works

Interindividual Differences in Caffeine Metabolism and Factors Driving Caffeine Consumption

Nehlig, A. (2018) · Pharmacological Reviews · doi:10.1124/pr.117.014407 · Cited by 632 · see citing works

Sex differences in Parkinson’s disease

Gillies, G. E., Pienaar, I. S., Vohra, S., & Qamhawi, Z. (2014) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2014.02.002 · Cited by 495 · see citing works

Role of estrogen receptors in health and disease

Chen, P., Li, B., & Ou-Yang, L. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.839005 · Cited by 339 · see citing works

Incidence of Parkinson's disease in Norway: the Norwegian ParkWest study

Alves, G. W., Müller, B. P., Herlofson, K., Hogenesch, I., Telstad, W., Aarsland, D., Tysnes, O., Larsen, J. O., & for the Norwegian ParkWest study group (2009) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2008.168211 · Cited by 269 · see citing works

Coffee Consumption, Gender, and Parkinson’s Disease Mortality in the Cancer Prevention Study II Cohort: The Modifying Effects of Estrogen

Ascherio, A. (2004) · American Journal of Epidemiology · doi:10.1093/aje/kwh312 · Cited by 232 · see citing works

Dose–response meta‐analysis on coffee, tea and caffeine consumption with risk of P arkinson's disease

Qi, H., & Li, S. (2013) · Geriatrics and gerontology international/Geriatrics & gerontology international · doi:10.1111/ggi.12123 · Cited by 234 · see citing works

Postmenopausal Estrogen Use Affects Risk for Parkinson Disease

Currie, L. J., Harrison, M. B., Trugman, J. M., Bennett, J. P., & Wooten, G. F. (2004) · Archives of Neurology · doi:10.1001/archneur.61.6.886 · Cited by 226 · see citing works

Freezing of gait in Parkinson’s disease: pathophysiology, risk factors and treatments

Gao, C., Liu, J., Tan, Y., & Chen, S. (2020) · Translational Neurodegeneration · doi:10.1186/s40035-020-00191-5 · Cited by 223 · see citing works

PI3 kinase/Akt activation mediates estrogen and IGF‐1 nigral DA neuronal neuroprotection against a unilateral rat model of Parkinson's disease

Quesada, A., Lee, B. Y., & Micevych, P. E. (2008) · Developmental Neurobiology · doi:10.1002/dneu.20609 · Cited by 187 · see citing works

Sex and Gender Differences in Central Nervous System-Related Disorders

Zagni, E., Simoni, L., & Colombo, D. (2016) · Neuroscience Journal · doi:10.1155/2016/2827090 · Cited by 173 · see citing works

Reproductive Steroid Regulation of Mood and Behavior

Schiller, C. E., Johnson, S., Abate, A., Schmidt, P. J., & Rubinow, D. R. (2016) · Comprehensive physiology · doi:10.1002/cphy.c150014 · Cited by 217 · see citing works

The Impact of Estrogen and Estrogen-Like Molecules in Neurogenesis and Neurodegeneration: Beneficial or Harmful?

Bustamante-Barrientos, F. A., Méndez-Ruette, M., Ortloff, A., Luz‐Crawford, P., Rivera, F. J., Figueroa, C. D., Molina, L., & Bátiz, L. F. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.636176 · Cited by 174 · see citing works

Risk of Parkinson disease in women

Ragonese, P., D’Amelio, M., Salemi, G., Aridon, P., Gammino, M., Epifanio, A., Morgante, F., & Savettieri, G. (2004) · Neurology · doi:10.1212/wnl.62.11.2010 · Cited by 158 · see citing works

Age Cutoff for Early‐Onset Parkinson's Disease: Recommendations from the International Parkinson and Movement Disorder Society Task Force on Early Onset Parkinson's Disease

Mehanna, R., Śmiłowska, K., Fleisher, J. E., Post, B., Hatano, T., Piemonte, M. E. P., Kumar, K. R., McConvey, V., Zhang, B., Tan, E., et al. (2022) · Movement Disorders Clinical Practice · doi:10.1002/mdc3.13523 · Cited by 155 · see citing works

Young-onset Parkinson's disease: Its unique features and their impact on quality of life

Mehanna, R., & Jankovic, J. J. (2019) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2019.06.001 · Cited by 142 · see citing works

Psychiatric aspects of Parkinson’s disease

Grover, S., Somaiya, M. P., Kumar, S., & Avasthi, A. (2014) · Journal of Neurosciences in Rural Practice · doi:10.4103/0976-3147.143197 · Cited by 113 · see citing works

Brain renin-angiotensin system and dopaminergic cell vulnerability

Labandeira-García, J. L., Garrido‐Gil, P., Rodríguez‐Pallares, J., Valenzuela, R., Borrajo, A., & Rodriguez-Perez, A. I. (2014) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2014.00067 · Cited by 113 · see citing works

Protective Microglia and Their Regulation in Parkinson’s Disease

Le, W., Wu, J., & Tang, Y. (2016) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2016.00089 · Cited by 112 · see citing works

Effect of Caffeine Consumption on the Risk for Neurological and Psychiatric Disorders: Sex Differences in Human

Jee, H. J., Lee, S. G., Bormate, K. J., & Jung, Y.-S. (2020) · Nutrients · doi:10.3390/nu12103080 · Cited by 111 · see citing works

Differences in the Presentation and Progression of Parkinson's Disease by Sex

Iwaki, H., Blauwendraat, C., Leonard, H. L., Makarious, M. B., Kim, J. J., Liu, G., Maple‐Grødem, J., Corvol, J., Pihlstrøm, L., van Nimwegen, M., et al. (2020) · Movement Disorders · doi:10.1002/mds.28312 · Cited by 103 · see citing works

Sex differences in Parkinson’s disease

Lubomski, M., Rushworth, R. L., Lee, W., Bertram, K., & Williams, D. R. (2014) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2013.12.016 · Cited by 101 · see citing works

Gender disparities in Parkinson’s disease

Shulman, L. M., & Bhat, V. (2006) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.6.3.407 · Cited by 96 · see citing works

OESTROGEN AND NIGROSTRIATAL DOPAMINERGIC NEURODEGENERATION: ANIMAL MODELS AND CLINICAL REPORTS OF PARKINSON'S DISEASE

Liu, B., & Dluzen, D. E. (2007) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2007.04616.x · Cited by 95 · see citing works

Exploration of changes in disability after menopause in a longitudinal multiple sclerosis cohort

Bove, R. M., Healy, B. C., Musallam, A., Glanz, B. I., Jager, P. L. D., & Chitnis, T. (2015) · Multiple Sclerosis Journal · doi:10.1177/1352458515606211 · Cited by 90 · see citing works

Nuclear factor‐kappa B (NF‐κB) in pathophysiology of Parkinson disease: Diverse patterns and mechanisms contributing to neurodegeneration

Dolatshahi, M., Hameghavandi, M. H. R., Sabahi, M., & Rostamkhani, S. (2021) · European Journal of Neuroscience · doi:10.1111/ejn.15242 · Cited by 85 · see citing works

Parkinson's disease in women: A call for improved clinical studies and for comparative effectiveness research

Pavon, J. M., Whitson, H. E., & Okun, M. S. (2010) · Maturitas · doi:10.1016/j.maturitas.2010.01.001 · Cited by 84 · see citing works

Influence of Estrogen Modulation on Glia Activation in a Murine Model of Parkinson's Disease

Siani, F., Greco, R., Levandis, G., Ghezzi, C., Daviddi, F., Demartini, C., Vegeto, E., Armentero, M., & Blandini, F. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00306 · Cited by 75 · see citing works

Inhibition of Rho kinase mediates the neuroprotective effects of estrogen in the MPTP model of Parkinson's disease

Rodriguez-Perez, A. I., Dominguez‐Meijide, A., Lanciego, J. L., Guerra, M. J., & Labandeira-García, J. L. (2013) · Neurobiology of Disease · doi:10.1016/j.nbd.2013.06.004 · Cited by 69 · see citing works

Estrogen and angiotensin interaction in the substantia nigra. Relevance to postmenopausal Parkinson's disease

Rodriguez-Perez, A. I., Valenzuela, R., Villar‐Cheda, B., Guerra, M. J., Lanciego, J. L., & Labandeira-García, J. L. (2010) · Experimental Neurology · doi:10.1016/j.expneurol.2010.05.015 · Cited by 69 · see citing works

Association Between the Ubiquitin Carboxyl-Terminal Esterase L1 Gene (UCHL1) S18Y Variant and Parkinson's Disease: A HuGE Review and Meta-Analysis

Ragland, M. F., Hutter, C., Zabetian, C. P., & Edwards, K. L. (2009) · American Journal of Epidemiology · doi:10.1093/aje/kwp288 · Cited by 64 · see citing works

Dopaminergic neuroprotection of hormonal replacement therapy in young and aged menopausal rats: role of the brain angiotensin system

Rodriguez-Perez, A. I., Valenzuela, R., Villar‐Cheda, B., Guerra, M. J., & Labandeira-García, J. L. (2011) · Brain · doi:10.1093/brain/awr320 · Cited by 61 · see citing works

Parkinson's disease and pregnancy: An updated review

Seier, M., & Hiller, A. (2017) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2017.05.007 · Cited by 61 · see citing works

l-Dopa-Induced Dyskinesia—Clinical Presentation, Genetics, and Treatment

Kukkle, P. L., Fox, S. H., & Meissner, W. G. (2011) · International review of neurobiology · doi:10.1016/b978-0-12-381328-2.00002-x · Cited by 56 · see citing works

Parkinson's Disease: Mitochondrial Molecular Pathology, Inflammation, Statins, and Therapeutic Neuroprotective Nutrition

KONES, R. J. (2010) · Nutrition in Clinical Practice · doi:10.1177/0884533610373932 · Cited by 55 · see citing works

Rho Kinase and Dopaminergic Degeneration: A Promising Therapeutic Target for Parkinson’s Disease

Labandeira-Garcia, J. L., Rodríguez-Perez, A. I., Villar-Cheda, B., Borrajo, A., Dominguez-Meijide, A., & Guerra, M. J. (2015) · The Neuroscientist · doi:10.1177/1073858414554954 · Cited by 54 · see citing works

Aging, Angiotensin system and dopaminergic degeneration in the substantia nigra.

Labandeira-García, J. L., Rodríguez‐Pallares, J., Villar‐Cheda, B., Rodriguez-Perez, A. I., Garrido‐Gil, P., & Guerra, M. J. (2011) · Europe PMC (PubMed Central) · Cited by 50 · see citing works

The role of the brain renin-angiotensin system in Parkinson´s disease

Labandeira-García, J. L., Labandeira, C. M., Guerra, M. J., & Rodriguez-Perez, A. I. (2024) · Translational Neurodegeneration · doi:10.1186/s40035-024-00410-3 · Cited by 46 · see citing works

Effect of long-term estrogen therapy on dopaminergic responsivity in post-menopausal women—a preliminary study

Craig, M., Cutter, W. J., Wickham, H., van Amelsvoort, T., RYMER, J. M., Whitehead, M. I., & Murphy, D. (2004) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2004.03.008 · Cited by 44 · see citing works

Astrogliosis and sexually dimorphic neurodegeneration and microgliosis in the olfactory bulb in Parkinson’s disease

Flores‐Cuadrado, A., Saiz‐Sánchez, D., Mohedano‐Moriano, A., Lamas-Cenjor, E., Leon-Olmo, V., Martı́nez-Marcos, A., & Úbeda‐Bañón, I. (2021) · npj Parkinson s Disease · doi:10.1038/s41531-020-00154-7 · Cited by 42 · see citing works

Reproductive Steroid Regulation of Mood and Behavior

Schiller, C. E., Johnson, S., Abate, A. C., Schmidt, P. J., & Rubinow, D. R. (2016) · Comprehensive physiology · doi:10.1002/j.2040-4603.2016.tb00705.x · Cited by 41 · see citing works

Gender differences in the association between antidepressant use and restless legs syndrome

Baughman, K. R., Bourguet, C. C., & Ober, S. K. (2009) · Movement Disorders · doi:10.1002/mds.22517 · Cited by 38 · see citing works

Gender‐related differences in the human subthalamic area: a local field potential study

Marceglia, S. R. F., Mrakic‐Sposta, S., Foffani, G., Cogiamanian, F. M., Caputo, E., Egidi, M., Barbieri, S., & Priori, A. (2006) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2006.05208.x · Cited by 38 · see citing works

Coronal plane spinal malalignment and Parkinson's disease: prevalence and associations with disease severity

Choi, H. J., Smith, J. S., Shaffrey, C. I., Lafage, V., Schwab, F., Ames, C. P., Matsumoto, M., Baik, J. S., & Ha, Y. S. (2014) · The Spine Journal · doi:10.1016/j.spinee.2014.07.004 · Cited by 37 · see citing works

Reproductive factors and Parkinson's disease: A multicenter case–control study

Nicoletti, A. S. Q., Nicoletti, G., Arabia, G., Annesi, G., Mari, M. D., Lamberti, P., Grasso, L., Marconi, R., Epifanio, A., Morgante, L., et al. (2011) · Movement Disorders · doi:10.1002/mds.23951 · Cited by 37 · see citing works

Failure of estrogen to protect the substantia nigra pars compacta of female rats from lesion induced by 6-hydroxydopamine

Ferraz, A. C., Xavier, L. L., Hernandes, S., Sulzbach, M. L., Viola, G. G., Anselmo-Franci, J. A., Achaval, M., & Cunha, C. D. (2003) · Brain Research · doi:10.1016/s0006-8993(03)03198-6 · Cited by 37 · see citing works

Brain angiotensin and dopaminergic degeneration: relevance to Parkinson's disease.

Labandeira-García, J. L., Rodríguez‐Pallares, J., Rodriguez-Perez, A. I., Garrido‐Gil, P., Villar‐Cheda, B., Valenzuela, R., & Guerra, M. J. (2012) · Europe PMC (PubMed Central) · Cited by 36 · see citing works

Young onset Parkinson's disease. Practical management of medical issues

Calne, S. M., & Kumar, A. (2007) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2007.07.007 · Cited by 36 · see citing works

Gut and Vagina Microbiota Associated With Estrus Return of Weaning Sows and Its Correlation With the Changes in Serum Metabolites

Zhang, J., Liu, M., Ke, S., Huang, X., Fang, S., He, M., Fu, H., Chen, C., & Huang, L. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.690091 · Cited by 35 · see citing works

Neuroactive Steroids, Toll-like Receptors, and Neuroimmune Regulation: Insights into Their Impact on Neuropsychiatric Disorders

Balan, I. S., Boero, G., Chéry, S. L., McFarland, M. H., Lopez, A. G., & Morrow, A. L. (2024) · Life · doi:10.3390/life14050582 · Cited by 33 · see citing works

Effects of progesterone administered after MPTP on dopaminergic neurons of male mice

Litim, N., Morissette, M., & Paolo, T. D. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.02.007 · Cited by 32 · see citing works

A CD14 monocyte receptor polymorphism and genetic susceptibility to Parkinson's disease for females

Lin, J.-J., Chen, C., Yueh, K.-C., Chang, C. Y., & Lin, S. Z. (2005) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2005.07.010 · Cited by 30 · see citing works

Disruption of latent inhibition induced by ovariectomy can be reversed by estradiol and clozapine as well as by co-administration of haloperidol with estradiol but not by haloperidol alone

Arad, M., & Weiner, I. (2009) · Psychopharmacology · doi:10.1007/s00213-009-1464-0 · Cited by 30 · see citing works

Predictors of camptocormia in patients with Parkinson's disease: A prospective study from southwest China

Ou, R., Liu, H., Hou, Y., Song, W., Cao, B., Wei, Q., Yuan, X., Chen, Y., Zhao, B., & Shang, H. (2018) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2018.03.020 · Cited by 29 · see citing works

Reproductive factors and Parkinson's disease risk in Danish women

Greene, N., Lassen, C. F., Rugbjerg, K., & Ritz, B. R. (2014) · European Journal of Neurology · doi:10.1111/ene.12450 · Cited by 28 · see citing works

Survival of Huntington’s disease patients in Serbia: longer survival in female patients

Pekmezovic, T. D., Svetel, M. V., Maric, J., Dujmović, I., Dragašević, N., Marković, M. K., Romac, S. P., & Kostić, V. (2007) · European Journal of Epidemiology · doi:10.1007/s10654-007-9157-7 · Cited by 26 · see citing works

Sexual Dimorphism in Neurodegenerative Diseases and in Brain Ischemia

Zalewska, T., Pawelec, P., Ziąbska, K., & Ziemka‐Nałęcz, M. (2022) · Biomolecules · doi:10.3390/biom13010026 · Cited by 22 · see citing works

Preventive Effects of Soy Meal (±Isoflavone) on Spatial Cognitive Deficiency and Body Weight in an Ovariectomized Animal Model of Parkinson's Disease

Sarkaki, A., Badavi, M., Aligholi, H., & Moghaddam, A. Z. (2009) · Pakistan Journal of Biological Sciences · doi:10.3923/pjbs.2009.1338.1345 · Cited by 22 · see citing works

Effect of Different Doses of Estrogen on the Nigrostriatal Dopaminergic System in Two 6-Hydroxydopamine-Induced Lesion Models of Parkinson’s Disease

Cordellini, M. F., Piazzetta, G., Pinto, K. C., Delattre, A. M., Matheussi, F., Carolino, R. O. G., Szawka, R. E., Anselmo-Franci, J. A., & Ferraz, A. C. (2011) · Neurochemical Research · doi:10.1007/s11064-011-0428-z · Cited by 22 · see citing works

Metallic nanomaterials in Parkinson's disease: a transformative approach for early detection and targeted therapy

Mansour, A., Eldin, M. H., & El-sherbiny, I. M. (2025) · Journal of Materials Chemistry B · doi:10.1039/d4tb02428a · Cited by 22 · see citing works

Sex differences in the association between nonalcoholic fatty liver disease and Parkinson's disease

Jeong, S., Lee, H. R., Jang, W., Kim, D., Yoo, J. E., Jeon, K. H., Jin, S., Han, K., & Shin, D. W. (2021) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2021.10.030 · Cited by 21 · see citing works

Progesterone exerts a neuroprotective action in a Parkinson’s disease human cell model through membrane progesterone receptor α (mPRα/PAQR7)

Castelnovo, L. F., & Thomas, P. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1125962 · Cited by 20 · see citing works

Mechanisms linking neurological disorders with reproductive endocrine dysfunction: Insights from epilepsy research

Cutia, C. A., & Christian, C. A. (2023) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2023.101084 · Cited by 22 · see citing works

Sex as a Determinant of Age-Related Changes in the Brain

Burmistrov, D. E., Gudkov, S. V., Franceschi, C., & Vedunova, M. V. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25137122 · Cited by 21 · see citing works

Chorea gravidarum

Robottom, B., & Weiner, W. J. (2011) · Handbook of clinical neurology · doi:10.1016/b978-0-444-52014-2.00015-x · Cited by 19 · see citing works

Movement disorders in women: A review

Rabin, M., Stevens‐Haas, C., Havrilla, E., Devi, T., & Kurlan, R. (2013) · Movement Disorders · doi:10.1002/mds.25723 · Cited by 18 · see citing works

Gender-dependent effect of coffee consumption on tremor severity in de novo Parkinson’s disease

Cho, B., Choi, S., & Kim, B. C. (2019) · BMC Neurology · doi:10.1186/s12883-019-1427-y · Cited by 18 · see citing works

Alteration of nuclear factor-kappaB pathway promote neuroinflammation depending on the functions of estrogen receptors in substantia nigra after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine treatment

Mitra, S., Ghosh, N., Sinha, P., Chakrabarti, N., & Bhattacharyya, A. (2016) · Neuroscience Letters · doi:10.1016/j.neulet.2016.01.046 · Cited by 17 · see citing works

Recuperative effect of estrogen on rotenone-induced experimental model of Parkinson’s disease in rats

Makav, M., & Eroğlu, H. A. (2021) · Environmental Science and Pollution Research · doi:10.1007/s11356-020-11985-5 · Cited by 16 · see citing works

Postmenopausal effects of intrastriatal estrogen on catalepsy and pallidal electroencephalogram in an animal model of Parkinson's disease

Sarkaki, A., Badavi, M., Nejad, K. H., Gharibnaseri, M. K., & Rahim, F. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2008.02.022 · Cited by 15 · see citing works

Fas/FasL-mediated apoptosis in the arcuate nucleus and medial preoptic area of male ArKO mice is ameliorated by selective estrogen receptor alpha and estrogen receptor beta agonist treatment, respectively

Hill, R., Chow, J. D. Y., Fritzemeier, K., Simpson, E. R., & Boon, W. C. (2007) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2007.05.012 · Cited by 15 · see citing works

Water extract of Er-xian decoction selectively exerts estrogenic activities and interacts with SERMs in estrogen-sensitive tissues

Wong, K., Zhou, L., Yu, W., Poon, C. C., Xiao, H.-H., Chan, C.-O., Mok, D. K., & Wong, M. (2021) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2021.114096 · Cited by 14 · see citing works

17β-Estradiol/N-acetylcysteine interaction enhances the neuroprotective effect on dopaminergic neurons in the weaver model of dopamine deficiency

Botsakis, K., Theodoritsi, S., Grintzalis, K., Angelatou, F., Antonopoulos, I., Georgiou, C. D., Margarity, M., Matsokis, N. A., & Panagopoulos, N. T. (2016) · Neuroscience · doi:10.1016/j.neuroscience.2016.01.068 · Cited by 13 · see citing works

Association between urinary caffeine and caffeine metabolites and stroke in American adults: a cross-sectional study from the NHANES, 2009–2014

Fan, J., Yuan, Y., Zhang, X., Li, W., Ma, W., Wang, W., Gu, J., & Zhou, B. (2023) · Scientific Reports · doi:10.1038/s41598-023-39126-1 · Cited by 13 · see citing works

Paroxysmal Non-Kinesigenic Dyskinesia Caused by the Mutation of MR-1 in a Large Polish Kindred

Friedman, A., Zakrzewska‐Pniewska, B., Domitrz, I., Lee, H.-Y., Ptáček, L. J., & Kwieciński, H. (2008) · European Neurology · doi:10.1159/000165348 · Cited by 12 · see citing works

Alteration in nuclear factor-kappaB pathway and functionality of estrogen via receptors promote neuroinflammation in frontal cortex after 1-Methyl-4-Phenyl-1,2,3,6-tetrahydropyridine treatment

Mitra, S., Ghosh, N., Sinha, P., Chakrabarti, N., & Bhattacharyya, A. (2015) · Scientific Reports · doi:10.1038/srep13949 · Cited by 11 · see citing works

Sex and Parkinson's disease: a world of difference?

Burn, D. J. (2007) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2006.109991 · Cited by 11 · see citing works

Non-genetic factors associated with the risk of Parkinson�s disease in Iranian patients

tabatabaei, N. H. (2013) · Functional Neurology · doi:10.11138/fneur/2013.28.2.107 · Cited by 10 · see citing works

“Good” and “Bad” Microglia in Parkinson’s Disease: An Understanding of Homeostatic Mechanisms in Immunomodulation

Tang, Y., & Le, W. (2014) · Springer eBooks · doi:10.1007/978-3-319-08046-8_4 · Cited by 9 · see citing works

Assessing the association of coffee consumption on the relationship of chronic pain with depression and anxiety

Qin, X., Li, C., Wei, W., He, D., Zhao, Y., Cai, Q., Zhang, N., Chu, X., Shi, S., & Zhang, F. (2023) · Nutritional Neuroscience · doi:10.1080/1028415x.2023.2175412 · Cited by 9 · see citing works

Reproductive Lifespan and Motor Progression of Parkinson’s Disease

Ou, R., Wei, Q., Hou, Y., Zhang, L., Liu, K., Lin, J., Yang, T., Yang, J., Jiang, Z., Song, W., et al. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11206163 · Cited by 7 · see citing works

Animal Approaches to Studying Risk Factors for Parkinson’s Disease: A Narrative Review

Silva, R. H., Lopes-Silva, L. B., Cunha, D. G., Becegato, M. S., Ribeiro, A. M., & dos Santos, J. R. D. C. M. (2024) · Brain Sciences · doi:10.3390/brainsci14020156 · Cited by 8 · see citing works

Endocrine Disruptors (Xenoestrogens): An Overview

Dimogerontas, G., & Liapi, C. A. (2013) · Springer eBooks · doi:10.1007/978-3-642-29687-1_1 · Cited by 8 · see citing works

Aromatase and its inhibition in behaviour, obsessive compulsive disorder and parkinsonism

Boon, W. C., & Horne, M. K. (2011) · Steroids · doi:10.1016/j.steroids.2011.02.031 · Cited by 6 · see citing works

Contribution of Five Functional Loci of Dopamine Metabolism-Related Genes to Parkinson’s Disease and Multiple System Atrophy in a Chinese Population

Chen, Y., Ou, R., Zhang, L., Gu, X., Yuan, X., Wei, Q., Cao, B., Zhao, B., Wu, Y., & Shang, H. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00889 · Cited by 5 · see citing works

Small molecule inhibitors targeting alpha-synuclein aggregation: Progress and future outlook

Hajam, I. B., Ahanger, I. A., Rasool, U., & Dar, T. A. (2025) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2025.08.017 · Cited by 4 · see citing works

Sex-dependent immune activation shapes disease progression in a model of Parkinson’s disease

Beauchamp, L. C., Palumbo, L. A., Lanser, T. B., Baig, M., & Cox, L. M. (2025) · Biology of Sex Differences · doi:10.1186/s13293-025-00809-1 · Cited by 4 · see citing works

Combined inhibition of dopamine D1/D2 receptors induces cognitive and emotional dysfunction through oxidative stress and dopaminergic neuron damage

Li, X., Zhuang, Y., Zhang, Y., Fan, K. K., Chen, X., Chen, X., Liu, X., Sun, J., & Liu, L. (2025) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2025.1621017 · Cited by 3 · see citing works

Dual disease co-expression analysis reveals potential roles of estrogen-related genes in postmenopausal osteoporosis and Parkinson’s disease

Yu, D., Kang, J., Ju, C., Wang, Q., Qiao, Y., Qiao, L., & Yang, D. (2025) · Frontiers in Genetics · doi:10.3389/fgene.2024.1518471 · Cited by 2 · see citing works

Bilateral Oophorectomy or Hysterectomy with Ovarian Conservation and Risk of Parkinson's Disease: A Systematic Review and Meta‐Analysis

Derhab, M., Ellabbad, M. M., Muhammad, S., Hamouda, A. M., Tawela, A., Okar, L., Smith, C. Y., Savica, R., & Rocca, W. A. (2025) · Movement Disorders Clinical Practice · doi:10.1002/mdc3.70490 · Cited by 2 · see citing works

Involvement of nitric oxide in Parkinson's disease: Emphasis on sex difference in prevalence

Taşkıran, D., Nazlıel, B., İrkeç, C., Kutay, F., & Pöğün, Ş. (2003) · Neuroscience Research Communications · doi:10.1002/nrc.10068 · Cited by 2 · see citing works

Machine learning analysis of population-wide plasma proteins identifies hormonal biomarkers of Parkinson’s disease

Chaudhry, F. F., Kim, T. W., Elemento, O., & Betel, D. (2026) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2026.1730550 · Cited by 2 · see citing works

Neurotoxins and medicinals for the treatment of Parkinson’s disease. Part 3: Drugs indirectly influencing the dopaminergic system (a review)

Кадиева, M. Г., Тоникович, О. Э., & Муцуева, С. Х. (2005) · Pharmaceutical Chemistry Journal · doi:10.1007/s11094-006-0022-x · Cited by 2 · see citing works

Effects of L-dopa on expression of prolactin and synaptotagmin IV in 17-estradiol-induced prolactinomas of ovariectomized hemiparkinsonian rats

Zorović, M., Kolmančič, K., & Živin, M. (2021) · Bosnian Journal of Basic Medical Sciences · doi:10.17305/bjbms.2021.5491 · Cited by 2 · see citing works

Exploring the relationships between clinical manifestations and sex hormones, thyroid hormones, and menstrual factors in female Parkinson’s disease patients

Wang, F., Zhao, J., Du, J., Li, J., Wang, P., Zhong, Y., Feng, T., & Wan, Z. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1573768 · Cited by 1 · see citing works

Ulcerative colitis model triggers gut α-Synuclein aggregation without brain involvement or neuronal loss in female rats

Espinosa‐Oliva, A. M., Vázquez‐Carretero, M. D., Ruiz, R., Roca-Ceballos, M. A., García-Miranda, P., Peral, M. J., Soto, M. S., Herrera, A. J., Venero, J. L., & de Pablos, R. M. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1637548 · Cited by 1 · see citing works

Insights from a cross-sectional population-based study of 10,929 Australians living with Parkinson's disease: risk factors, comorbidities, and sex differences

Cao, F., McAloney, K., Ogonowski, N. S., García‐Marín, L. M., Díaz‐Torres, S., Flores‐Ocampo, V., Ceja, Z., Chafota, F., Parker, R., Ferguson, M., et al. (2026) · The Lancet Regional Health - Western Pacific · doi:10.1016/j.lanwpc.2026.101816 · Cited by 1 · see citing works

MODELO IN VITRO DE PARKINSONISMO EXPERIMENTAL INDUZIDO POR ROTENONA: INVESTIGAÇÃO DE MECANISMOS DE AÇÃO, NEUROPROTEÇÃO E MORTE CELULAR

Filho, M. N. P., & Jorge, A. B. N. (2011) · Cited by 1 · see citing works

MicroRNAs Contribute to the Protective Actions of 17β-Estradiol on the Vascular System

Rigassi, L. (2016) · Repository for Publications and Research Data (ETH Zurich) · doi:10.3929/ethz-a-010737742 · Cited by 1 · see citing works

Clinical and Neuroendocrinological Effects of Estrogens in Postmenopausal Women with Parkinson’s Disease

Bonuccelli, U., Piccini, P. P., Napolitano, A., Cagnacci, A., Melis, G. B., Corsini, G. U., & MURATORIO, A. (1991) · Advances in behavioral biology · doi:10.1007/978-1-4684-5871-8_79 · Cited by 1 · see citing works

The use of estrogen in the treatment of Parkinson's disease

Tsang, K. L., Jiang, H., Ramsden, D. B., & Ho, S. L. (2001) · Parkinsonism & Related Disorders · doi:10.1016/s1353-8020(01)00027-x · Cited by 11 · see citing works

Estrogen and Parkinson s disease

Kompoliti, K. (2003) · Frontiers in bioscience · doi:10.2741/1070 · Cited by 50 · see citing works

Estrogens and Parkinson's disease

Session, D. R., Pearlstone, M. M., Jewelewicz, R., & Kelly, A. C. (1995) · Maturitas · doi:10.1016/0378-5122(95)90004-7 · Cited by 3 · see citing works

Estrogen as Neuroprotectant of Nigrostriatal Dopaminergic System: Laboratory and Clinical Studies

Dluzen, D. E., & Horstink, M. W. I. M. (2003) · Endocrine · doi:10.1385/endo:21:1:67 · Cited by 106 · see citing works